By using Zepto-guided™ visual axis identification, I have a fixed frame of reference for the patient’s visual axis during surgery
FREMONT, Calif. (PRWEB) June 29, 2018
Fremont, California – June 29th, 2018 – Mynosys Cellular Devices, Inc. today announced that a peer-reviewed article, “Streamlined Method for Anchoring Cataract Surgery and Intraocular Lens Centration on the Patient’s Visual Axis”, was published by JCRS online and will be available in print in the Journal’s May issue. In this paper, the study’s author, Dr. Vance Thompson (Vance Thompson Vision, Sioux Falls, South Dakota) describes a procedure of performing intraoperative Zepto-guided™ visual axis centration during cataract surgery. This procedure translates the patient’s visual axis into a surgical reference landmark that guides the surgeon’s placement of the capsulotomy and the IOL. This intraoperative axis identification and centration method is based on the use of patient fixation, co-axial microscope optics and Purkinje images as originally described by Daniel Chang M.D. and George Waring IV M.D.
“By using Zepto-guided™ visual axis identification, I have a fixed frame of reference for the patient’s visual axis during surgery” explains Dr. Thompson. “This helps eliminate guesswork on where to position the capsulotomy and the Zepto-guided™ capsulotomy almost always ends up being where the IOL naturally positions itself within the capsular bag.” Dr. Thompson adds “I now consistently obtain complete capsular overlap in all cases, which we all know provides greater stability against lens tilt and decentration.” “Additionally, positioning on the visual axis is important for best optical performance from premium IOLs and together with less lens tilt may help minimize dysphotopsias.” “The paper was submitted last October and was based on my first 86 consecutive cases. “I now routinely use this Zepto® guidance and have performed this procedure now in over 1,000 cases.”
“Zepto-guided™ visual axis centration takes advantage of several unique features of the Zepto® device” explains Kevin Waltz M.D. (CMO, Mynosys Inc.) “Its transparency allows the patient to follow the surgeon’s fixation instructions and suction allows quick and secure translation of the patient’s visual axis into a reference capsulotomy.” “We are very excited by the opportunity for Zepto® to assist surgeons to achieve consistent outcomes every time and improve cataract surgery for all patients.”
Research was supported by the National Eye Institute / National Institutes of Health under award no. R44EY021023. The content is solely the responsibility of the authors and does not necessarily represent the views of the NIH.